CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Eberhard Karls Universitt Tbingen Medizinische Fakultt's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 4, 2019Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna1